Actively Recruiting

Phase 3
Age: 40Years - 70Years
All Genders
NCT06846281

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

Led by Novartis Pharmaceuticals · Updated on 2026-05-12

360

Participants Needed

102

Research Sites

308 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this Phase 3b study is to assess the efficacy, safety and tolerability of remibrutinib after switching from ocrelizumab and compared to continuous ocrelizumab treatment, in patients living with relapsing multiple sclerosis (plwRMS).

CONDITIONS

Official Title

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

Who Can Participate

Age: 40Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female aged 40 to 70 years (inclusive)
  • Diagnosis of relapsing multiple sclerosis according to the 2017 McDonald diagnostic criteria
  • Currently treated with ocrelizumab at standard dose
  • Neurologically stable within 30 days before enrollment
  • Suitable for switching to remibrutinib based on physician judgement or patient preference
Not Eligible

You will not qualify if you...

  • Diagnosis of primary progressive multiple sclerosis according to the revised 2017 McDonald criteria
  • History of clinically significant central nervous system diseases or neurological disorders other than MS
  • History of confirmed progressive multifocal leukoencephalopathy or related neurological symptoms
  • Active clinically significant bacterial, viral, parasitic, or fungal infections
  • Active chronic immune system diseases other than MS
  • Severe cardiac disease or significant abnormalities on ECG
  • Unable to undergo MRI scans
  • History of life-threatening infusion or injection reactions to ocrelizumab

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 102 locations

1

Perseverance Research Center

Scottsdale, Arizona, United States, 85253

Actively Recruiting

2

Medstar Washington Hospital Center

Washington D.C., District of Columbia, United States, 20010-2975

Actively Recruiting

3

Neurology of Central FL Res Ctr

Altamonte Springs, Florida, United States, 32714

Actively Recruiting

4

University of Florida

Gainesville, Florida, United States, 32610

Actively Recruiting

5

Neurology Associates PA

Maitland, Florida, United States, 32751

Actively Recruiting

6

Aqualane Clinical Research

Naples, Florida, United States, 34105

Actively Recruiting

7

Advent Health Orlando

Orlando, Florida, United States, 32803

Actively Recruiting

8

Orlando Health Clinical Trials

Orlando, Florida, United States, 32806

Actively Recruiting

9

Tallahassee Neurological Clinic

Tallahassee, Florida, United States, 32308

Actively Recruiting

10

University Of South Florida

Tampa, Florida, United States, 33612

Actively Recruiting

11

Vero Beach Neurology

Vero Beach, Florida, United States, 32960

Actively Recruiting

12

Rush University Medical Center

Chicago, Illinois, United States, 60607

Actively Recruiting

13

University of Kansas Hospital

Kansas City, Kansas, United States, 66160

Actively Recruiting

14

MedStar Montgomery Medical Center

Olney, Maryland, United States, 20832

Actively Recruiting

15

Tufts Medical Center

Boston, Massachusetts, United States, 02111

Actively Recruiting

16

Lahey Hospital and Medical Center

Burlington, Massachusetts, United States, 01805

Actively Recruiting

17

Neurology Center of New England PC

Foxborough, Massachusetts, United States, 02035

Actively Recruiting

18

Michigan Institute of Neurological

Farmington Hills, Michigan, United States, 48334

Actively Recruiting

19

Memorial HC Ins for Neuroscience

Owosso, Michigan, United States, 48867

Actively Recruiting

20

WA Uni School Of Med

St Louis, Missouri, United States, 63110

Actively Recruiting

21

Cleveland Clinic Foundation

Las Vegas, Nevada, United States, 89106

Actively Recruiting

22

Holy Name Medical Center

Teaneck, New Jersey, United States, 07666

Actively Recruiting

23

University of New Mexico

Albuquerque, New Mexico, United States, 87131-0001

Actively Recruiting

24

SUNY Buffalo The Jacobs Neuro Inst

Buffalo, New York, United States, 14203

Actively Recruiting

25

Velocity Clinical Research

Raleigh, North Carolina, United States, 27607

Actively Recruiting

26

Sanford Health

Fargo, North Dakota, United States, 58122

Actively Recruiting

27

Premier Health

Centerville, Ohio, United States, 45459

Actively Recruiting

28

Univ of Cincinnati Medical Center

Cincinnati, Ohio, United States, 45219

Actively Recruiting

29

Cleveland Clinic Foundation

Cleveland, Ohio, United States, 44195

Actively Recruiting

30

Ohio Health Research Institute

Columbus, Ohio, United States, 43214

Actively Recruiting

31

Premier Neurology

Greenville, South Carolina, United States, 29605

Actively Recruiting

32

Sibyl Wray MD Neurology PC

Knoxville, Tennessee, United States, 37922

Actively Recruiting

33

Austin Regional Clinic

Austin, Texas, United States, 78731

Actively Recruiting

34

Univ of Texas Southwest Med Center

Dallas, Texas, United States, 75390-9034

Actively Recruiting

35

John Peter Smith Hospital

Fort Worth, Texas, United States, 76104

Actively Recruiting

36

Saturn Research Solutions LLC

Plano, Texas, United States, 75024

Actively Recruiting

37

Center for Neurological Disorders G

Greenfield, Wisconsin, United States, 53228-1321

Actively Recruiting

38

Novartis Investigative Site

Rosario, Santa Fe Province, Argentina, 2000

Actively Recruiting

39

Novartis Investigative Site

Rosario, Santa Fe Province, Argentina, S2000BZL

Actively Recruiting

40

Novartis Investigative Site

Buenos Aires, Argentina, C1012AAR

Actively Recruiting

41

Novartis Investigative Site

Buenos Aires, Argentina, C1055AAF

Actively Recruiting

42

Novartis Investigative Site

Melbourne, Victoria, Australia, 3004

Actively Recruiting

43

Novartis Investigative Site

Parkville, Victoria, Australia, 3050

Actively Recruiting

44

Novartis Investigative Site

Liverpool, Australia, 2170

Actively Recruiting

45

Novartis Investigative Site

St Leonards, Australia, 2065

Actively Recruiting

46

Novartis Investigative Site

Bruges, Belgium, 8000

Actively Recruiting

47

Novartis Investigative Site

Overpelt, Belgium, 3900

Actively Recruiting

48

Novartis Investigative Site

São Paulo, São Paulo, Brazil, 04076-004

Actively Recruiting

49

Novartis Investigative Site

Vancouver, British Columbia, Canada, V6T 2A1

Actively Recruiting

50

Novartis Investigative Site

Lévis, Quebec, Canada, G6W 0M5

Actively Recruiting

51

Novartis Investigative Site

Montreal, Quebec, Canada, H4A 3T2

Actively Recruiting

52

Novartis Investigative Site

Aarhus N, Denmark, 8200

Actively Recruiting

53

Novartis Investigative Site

Glostrup Municipality, Denmark, 2600

Actively Recruiting

54

Novartis Investigative Site

Bordeaux, France, 33076

Actively Recruiting

55

Novartis Investigative Site

Clermont-Ferrand, France, 63003

Actively Recruiting

56

Novartis Investigative Site

Lille, France, 59000

Actively Recruiting

57

Novartis Investigative Site

Marseille, France, 13885

Actively Recruiting

58

Novartis Investigative Site

Nice, France, 06000

Actively Recruiting

59

Novartis Investigative Site

Nîmes, France, 30029

Actively Recruiting

60

Novartis Investigative Site

Paris, France, 75940

Actively Recruiting

61

Novartis Investigative Site

Poitiers, France, 86021

Actively Recruiting

62

Novartis Investigative Site

Strasbourg, France, 67000

Actively Recruiting

63

Novartis Investigative Site

Toulouse, France, 31059

Actively Recruiting

64

Novartis Investigative Site

Tours, France, 37044

Actively Recruiting

65

Novartis Investigative Site

Bochum, Germany, 44791

Actively Recruiting

66

Novartis Investigative Site

Chaïdári, Greece, 124 62

Actively Recruiting

67

Novartis Investigative Site

Larissa, Greece, 411 10

Actively Recruiting

68

Novartis Investigative Site

Thessaloniki, Greece, 53246

Actively Recruiting

69

Novartis Investigative Site

Bergamo, BG, Italy, 24127

Actively Recruiting

70

Novartis Investigative Site

Foggia, FG, Italy, 71122

Actively Recruiting

71

Novartis Investigative Site

Genova, GE, Italy, 16132

Actively Recruiting

72

Novartis Investigative Site

Milan, MI, Italy, 20132

Actively Recruiting

73

Novartis Investigative Site

Pavia, PV, Italy, 27100

Actively Recruiting

74

Novartis Investigative Site

Roma, RM, Italy, 00133

Actively Recruiting

75

Novartis Investigative Site

Roma, RM, Italy, 00168

Actively Recruiting

76

Novartis Investigative Site

Mexico City, Mexico City, Mexico, 06700

Actively Recruiting

77

Novartis Investigative Site

Mexico City, Mexico, 14050

Actively Recruiting

78

Novartis Investigative Site

Braga, Portugal, 4710243

Actively Recruiting

79

Novartis Investigative Site

Coimbra, Portugal, 3004-561

Actively Recruiting

80

Novartis Investigative Site

Lisbon, Portugal, 1169-050

Actively Recruiting

81

Novartis Investigative Site

Bratislava, Slovakia, 826 06

Actively Recruiting

82

Novartis Investigative Site

Trnava, Slovakia, 917 02

Actively Recruiting

83

Novartis Investigative Site

Cape Town, Western Cape, South Africa, 7405

Actively Recruiting

84

Novartis Investigative Site

Pretoria, South Africa, 0041

Actively Recruiting

85

Novartis Investigative Site

Majadahonda, Madrid, Spain, 28222

Actively Recruiting

86

Novartis Investigative Site

El Palmar, Murcia, Spain, 30120

Actively Recruiting

87

Novartis Investigative Site

Valencia, Valencia, Spain, 46017

Actively Recruiting

88

Novartis Investigative Site

Barcelona, Spain, 08035

Actively Recruiting

89

Novartis Investigative Site

Córdoba, Spain, 14004

Actively Recruiting

90

Novartis Investigative Site

Madrid, Spain, 28009

Actively Recruiting

91

Novartis Investigative Site

Madrid, Spain, 28034

Actively Recruiting

92

Novartis Investigative Site

Madrid, Spain, 28040

Actively Recruiting

93

Novartis Investigative Site

Málaga, Spain, 29010

Actively Recruiting

94

Novartis Investigative Site

Seville, Spain, 41009

Actively Recruiting

95

Novartis Investigative Site

Valencia, Spain, 46026

Actively Recruiting

96

Novartis Investigative Site

Bern, Switzerland, 3010

Actively Recruiting

97

Novartis Investigative Site

Lausanne, Switzerland, 1011

Actively Recruiting

98

Novartis Investigative Site

Zurich, Switzerland, 8091

Actively Recruiting

99

Novartis Investigative Site

Sheffield, South Yorkshire, United Kingdom, S10 2JF

Actively Recruiting

100

Novartis Investigative Site

Leeds, United Kingdom, LS1 3EX

Actively Recruiting

101

Novartis Investigative Site

London, United Kingdom, W6 8RF

Actively Recruiting

102

Novartis Investigative Site

Swansea, United Kingdom, SA6 6NL

Actively Recruiting

Loading map...

Research Team

N

Novartis Pharmaceuticals

CONTACT

N

Novartis Pharmaceuticals

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis. | DecenTrialz